Since NLRP3 inflammasome activation in HSCs as well as other innate cells in the bone marrow is integral to bone marrow aging and myelodysplastic syndromes, targeting NLRP3 is an interesting possibility to reverse inflamm-aging and promote homing and engraftment in transplant settings. Here, NLRP3 is linked to myelodysplastic syndrome.